Dm. Eble et al., MYOSIN HEAVY-CHAIN SYNTHESIS IS INCREASED IN A RABBIT MODEL OF HEART-FAILURE, American journal of physiology. Heart and circulatory physiology, 41(2), 1997, pp. 969-978
Chronic ventricular tachycardia (chronic VT) causes left ventricular (
LV) dysfunction and is associated with increased LV wall stress and ne
urohormonal activation, but no LV hypertrophy. The mechanisms responsi
ble for the lack of myocardial growth with chronic VT are unknown. Acc
ordingly, this study examined contractile protein [myosin heavy chain
(MHC)] synthesis in a rabbit model of chronic VT. MHC mRNA levels, pro
tein concentration, and synthesis rates were examined in control rabbi
ts (n = 18) and in rabbits with chronic VT (400 beats/min, 3 wk, n = 1
8). With chronic VT, LV end-diastolic volume increased (8.2 +/- 0.8 vs
. 5.3 +/- 0.6 mi, P < 0.05), ejection fraction decreased (12 +/- 3 vs.
38 +/- 4%, P < 0.05) and peak systolic wall stress increased (963 +/-
93 vs. 262 +/- 42 g/cm(2), P < 0.05). Plasma catecholamine and endoth
elin levels also increased threefold, and renin activity increased two
fold. Despite these stimuli for hypertrophy, LV mass-to-body weight ra
tio was unchanged (1.15 +/- 0.07 vs. 1.25 +/- 0.05 g/kg). At the myocy
te level, chronic VT caused myocyte lengthening (159.6 +/- 1.8 vs. 121
.6 +/- 1.4 mu m, P < 0.05), but a reduction in myocyte cross-sectional
area (199 +/- 6 vs. 249 +/- 7 mu m(2), P < 0.0001), as well as a redu
ced velocity of shortening (42.6 +/- 1.6 vs. 74.1 +/- 2.8 mu m/s, P <
0.05). Chronic VT resulted in a significant increase in the rate of MH
C synthesis, but paradoxically, there was no change in LV MHC content.
Despite increased MHC synthesis, relative levels of MHC mRNA were not
increased in chronic VT (2.79 +/- 0.23 vs. 2.44 +/- 0.20 AU, relative
to glyceraldehyde-3-phosphate dehydrogenase), suggesting an increase
in MHC translational efficiency. These unique findings suggest acceler
ated degradative processes must contribute to the failure of myocardia
l growth in this model of LV dysfunction in which increased LV wall st
ress, neurohormonal activation, and increased protein synthesis occurr
ed.